Search

Search Results
Results 3631 - 3640 of 8668 for Skin Cancer
  • News - 14 Jan 2026
    Therapies that target the utilization of fat by tumors and activate a type of cell death dependent on fat molecules may be a promising avenue to treat cancer, according to new research by UTHealth...
  • News - 14 Jan 2026
    In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the "recipe" for the transformation.
  • News - 2 Jan 2026
    Within tumors in the human body, there are immune cells (macrophages) capable of fighting cancer, but they have been unable to perform their roles properly due to suppression by the tumor.
  • Drug - 19 Dec 2025
    Consumer Medicine Information (CMI) about Iressa intended for persons living in Australia.
  • Drug - 18 Dec 2025
    Consumer Medicine Information (CMI) about Kliovance intended for persons living in Australia.
  • Drug - 18 Dec 2025
    Consumer Medicine Information (CMI) about Kliogest intended for persons living in Australia.
  • Drug - 18 Dec 2025
    Consumer Medicine Information (CMI) about Estrofem intended for persons living in Australia.
  • Drug - 18 Dec 2025
    Consumer Medicine Information (CMI) about Tecvayli intended for persons living in Australia.
  • Drug - 16 Dec 2025
    Consumer Medicine Information (CMI) about Talvey intended for persons living in Australia.
  • Drug - 16 Dec 2025
    Consumer Medicine Information (CMI) about Fragmin intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.